Researchers at NYU Langone Health said Wednesday that an experimental drug that blocks a key protein can trigger a form of self-destruction in lung...
Vous n'êtes pas connecté
Maroc - WN.COM - Science - 06/Nov 22:25
Small cell lung carcinoma, chromogranin immunostain. Credit: – CC BY-SA 2.0 via Wikimedia Commons. Researchers at NYU Langone Health said Wednesday that an experimental drug that blocks a key protein can trigger a form of self-destruction in lung cancer cells and dramatically slow tumor growth in mice, a finding published Nov. 5 in the journal Nature. The team reported that inhibiting ferroptosis suppressor protein 1, or FSP1, unleashes ferroptosis, a non-apoptotic cell-death process driven by iron-dependent lipid peroxidation, and reduced tumor growth by as much as 80% in mouse models of lung adenocarcinoma, the most common lung cancer among people who have never smoked. The study...
Researchers at NYU Langone Health said Wednesday that an experimental drug that blocks a key protein can trigger a form of self-destruction in lung...
Researchers at NYU Langone Health said Wednesday that an experimental drug that blocks a key protein can trigger a form of self-destruction in lung...
High levels of a specific protein can reduce the growth of tumour cells in neuroblastoma, a form of cancer that affects the sympathetic nervous system...
High levels of a specific protein can reduce the growth of tumour cells in neuroblastoma, a form of cancer that affects the sympathetic nervous system...
Aprea Therapeutics, Inc. (Nasdaq: APRE) is a clinical-stage biopharmaceutical company pioneering a new era in precision oncology. By combining deep...
By combining LED technology and nanomaterials, researchers have created a therapy that eliminates cancer cells using localized heat without damaging...
DelveInsight’s, “Small Cell Lung Cancer Pipeline Insight 2025” report provides comprehensive insights about 100+ companies and 100+...
DelveInsight’s, “Small Cell Lung Cancer Pipeline Insight 2025” report provides comprehensive insights about 100+ companies and 100+...
Rising Cancer Incidence Fuels Demand for Smart Nanomedicine Solutions in Oncology Care The Smart Cancer Nanomedicine Market represents a...
Rising Cancer Incidence Fuels Demand for Smart Nanomedicine Solutions in Oncology Care The Smart Cancer Nanomedicine Market represents a...